What is a potential side effect of Raloxifene (Evista)?

Raloxifene (Evista) is a selective estrogen receptor modulator (SERM) commonly used to prevent and treat osteoporosis in postmenopausal women. One of the notable potential side effects associated with its use is an increased risk of venous thromboembolism, which includes blood clots. This risk arises from the drug's estrogen-like effects on certain tissues, leading to changes in coagulation factors that can result in clot formation.

Weight gain, hair loss, and nausea are not commonly linked to Raloxifene. While some patients may experience gastrointestinal disturbances such as nausea, it is not a widely recognized side effect and is generally less significant compared to the potential for blood clots. Understanding the specific adverse effects of medications is crucial in monitoring patient safety and managing potential risks effectively.